+1 Recommend
1 collections
      • Record: found
      • Abstract: found
      • Article: found

      Effects of Dietary Protein on the Progression of Renal Failure in the Fawn-Hooded Rat

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          Fawn-Hooded (FH) rats on a normal protein intake develop focal glomerulosclerosis, proteinuria and hypertension and die prematurely because of renal failure. In the present study we examined the effect of a life long feeding of a low (12%)-protein (LP) diet and a high (36%)-protein (HP) diet on renal function, urinary protein excretion (U<sub>prot</sub>V), systolic blood pressure (SBP) and survival time. Compared to the LP diet, the HP diet initially raised the glomerular filtration rate (GFR) and the U<sub>prot</sub>V, while the SBP was about the same. The U<sub>prot</sub>V of rats on the HP diet increased steadily and the GFR started to decline after 40 weeks. The LP diet resulted in a prolonged period of stable renal function, limited proteinuria and an increased life span. In the 2nd year of life, the level of hypertension was less in FH rats on the HP diet. Throughout the study there was no relationship between the SBP and the U<sub>prot</sub>V. The low UprotV in FH rats on the LP diet points to a lower level of glomerular capillary pressure. The attenuated development of glomerular hypertension on the LP diet slows down the subsequent renal damage in FH rats. This is in agreement with the view that glomerular hypertension is an essential hemodynamic derangement responsible for progressive deterioration of glomerular function. As in other rat models, i.e. renal ablation or unilateral nephrectomy, the LP diet slowed down the development of renal failure but did not prevent it.

          Related collections

          Author and article information

          S. Karger AG
          10 December 2008
          : 55
          : 2
          : 203-209
          Department of Pediatric Surgery, Erasmus University Medical School, Rotterdam, The Netherlands
          185953 Nephron 1990;55:203–209
          © 1990 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 7
          Original Paper


          Comment on this article